Advertisement
Screener

LIQUIDIA TECHNOLOGIES, INC. Patents: Active

LIQUIDIA TECHNOLOGIES, INC. Active Patents

6 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-07-12: Application 18350926; Invention Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status Patented Case.
  • 2022-04-13: Application 17719439; Invention Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status Patented Case.
  • 2021-07-30: Application 17390514; Invention Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status Patented Case.
  • 2021-07-30: Application 17390476; Invention Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-07-1218350926Dry Powder Treprostinil for the Treatment of Pulmonary HypertensionLIQUIDIA TECHNOLOGIES, INC.Patented Case2025-08-1912390475US20230346799A1
Robert Frank Roscigno
Brian T. Farrer
Jacob J. Sprague
Benjamin Maynor
United States
United States
United States
United States
RONEY, CELESTE A
2022-04-1317719439Dry Powder Treprostinil for the Treatment of Pulmonary HypertensionLIQUIDIA TECHNOLOGIES, INC.Patented Case2023-05-3011660304US20220257608A1
Robert Frank Roscigno
Brian T. Farrer
Jacob J. Sprague
Benjamin Maynor
United States
United States
United States
United States
RONEY, CELESTE A
2021-07-3017390514Dry Powder Treprostinil for the Treatment of Pulmonary HypertensionLIQUIDIA TECHNOLOGIES, INC.Patented Case2023-09-0511744836US20210353641A1
Robert Frank Roscigno
Brian T. Farrer
Jacob J. Sprague
Benjamin Maynor
United States
United States
United States
United States
RONEY, CELESTE A
2021-07-3017390476Dry Powder Treprostinil for the Treatment of Pulmonary HypertensionLIQUIDIA TECHNOLOGIES, INC.Patented Case2023-09-0511744835US20210353640A1
Robert Frank Roscigno
Brian T. Farrer
Jacob J. Sprague
Benjamin Maynor
United States
United States
United States
United States
RONEY, CELESTE A
2020-11-2517104348Dry Powder Treprostinil for the Treatment of Pulmonary HypertensionLIQUIDIA TECHNOLOGIES, INC.Patented Case2023-08-0111712442US20210077504A1
Robert Frank Roscigno
Brian T. Farrer
Jacob J. Sprague
Benjamin Maynor
United States
United States
United States
United States
RONEY, CELESTE A
2018-11-0516099135Dry Powder Treprostinil for the Treatment of Pulmonary HypertensionLIQUIDIA TECHNOLOGIES, INC.Patented Case2021-01-2610898494US20190151332A1
Robert Frank Roscigno
Brian T. Farrer
Jacob J. Sprague
Benjamin Maynor
United States
United States
United States
United States
RONEY, CELESTE A